Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (1-10 of 775) with videos related to

Pageof 78
Sort By:
The Lancet. Neurology|May 30, 2020
Major risk factors for Alzheimer's disease: age and geneticsColin L Masters
The New England Journal of Medicine|August 8, 2014
Shaken, not sonicated?Colin L Masters
The Lancet. Neurology|January 25, 2025
Should the preclinical stage of Alzheimer's disease be disclosed?Colin L Masters
Pathology|December 12, 2024
Neuropathology meets chemical and genetic pathology head-on: a personal perspectiveColin L Masters
Brain : a Journal of Neurology|October 3, 2006
Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathwayColin L Masters, Konrad Beyreuther
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Pathways to the discovery of the Abeta amyloid of Alzheimer's diseaseColin L Masters, Konrad Beyreuther
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Henryk M. Wisniewski and the amyloid theory of Alzheimer's diseaseColin L. Masters, Konrad Beyreuther
Free Neuropathology|June 26, 2023
Vale Emeritus Professor Byron A Kakulas AO, 1932 - 2023Clive Harper, Colin L Masters
Journal of Alzheimer'S Disease : JAD|July 30, 2025
The structural foundations of anti-amyloid-β immunotherapies: Unravelling antibody-antigen interactions in Alzheimer's disease treatmentLuke A Miles, Colin L Masters
Neurology|October 27, 2022
A Tale of Two PlatformsDaniel J Barber, Colin L Masters
Pageof 78

Showing results (1-10 of 775) with videos related to

Sort By:
Pageof 78
The Lancet. Neurology|May 30, 2020
Major risk factors for Alzheimer's disease: age and geneticsColin L Masters
The New England Journal of Medicine|August 8, 2014
Shaken, not sonicated?Colin L Masters
The Lancet. Neurology|January 25, 2025
Should the preclinical stage of Alzheimer's disease be disclosed?Colin L Masters
Pathology|December 12, 2024
Neuropathology meets chemical and genetic pathology head-on: a personal perspectiveColin L Masters
Brain : a Journal of Neurology|October 3, 2006
Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathwayColin L Masters, Konrad Beyreuther
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Pathways to the discovery of the Abeta amyloid of Alzheimer's diseaseColin L Masters, Konrad Beyreuther
Journal of Alzheimer'S Disease : JAD|September 6, 2002
Henryk M. Wisniewski and the amyloid theory of Alzheimer's diseaseColin L. Masters, Konrad Beyreuther
Free Neuropathology|June 26, 2023
Vale Emeritus Professor Byron A Kakulas AO, 1932 - 2023Clive Harper, Colin L Masters
Journal of Alzheimer'S Disease : JAD|July 30, 2025
The structural foundations of anti-amyloid-β immunotherapies: Unravelling antibody-antigen interactions in Alzheimer's disease treatmentLuke A Miles, Colin L Masters
Neurology|October 27, 2022
A Tale of Two PlatformsDaniel J Barber, Colin L Masters
Pageof 78